Envista (NVST) Projected to Post Quarterly Earnings on Wednesday

Envista (NYSE:NVST) is expected to be issuing its Q1 2026 results after the market closes on Wednesday, May 6th. Analysts expect the company to announce earnings of $0.31 per share and revenue of $677.9480 million for the quarter. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. Parties are encouraged to explore the company’s upcoming Q1 2026 earning overview page for the latest details on the call scheduled for Wednesday, May 6, 2026 at 5:00 PM ET.

Envista (NYSE:NVST) last announced its quarterly earnings results on Thursday, February 5th. The company reported $0.38 EPS for the quarter, beating the consensus estimate of $0.32 by $0.06. Envista had a return on equity of 6.54% and a net margin of 1.73%.During the same period last year, the firm posted $0.24 EPS. The company’s quarterly revenue was up 15.0% on a year-over-year basis. On average, analysts expect Envista to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Envista Trading Down 0.8%

Shares of Envista stock traded down $0.21 during trading hours on Wednesday, hitting $26.28. The company’s stock had a trading volume of 444,115 shares, compared to its average volume of 2,707,117. Envista has a twelve month low of $15.49 and a twelve month high of $30.42. The firm has a fifty day moving average of $26.83 and a 200-day moving average of $23.84. The stock has a market cap of $4.28 billion, a price-to-earnings ratio of 93.66, a P/E/G ratio of 1.83 and a beta of 0.98. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.04 and a current ratio of 2.38.

Insider Transactions at Envista

In related news, SVP Mischa Reis sold 9,675 shares of the stock in a transaction dated Tuesday, February 10th. The stock was sold at an average price of $30.00, for a total transaction of $290,250.00. Following the transaction, the senior vice president owned 32,382 shares of the company’s stock, valued at approximately $971,460. This represents a 23.00% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.99% of the company’s stock.

Hedge Funds Weigh In On Envista

Hedge funds have recently bought and sold shares of the company. Caitong International Asset Management Co. Ltd lifted its stake in Envista by 16,711.1% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock worth $31,000 after acquiring an additional 1,504 shares in the last quarter. UMB Bank n.a. lifted its stake in Envista by 46.1% during the 4th quarter. UMB Bank n.a. now owns 2,017 shares of the company’s stock worth $44,000 after acquiring an additional 636 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in Envista by 73.1% during the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock worth $44,000 after acquiring an additional 949 shares in the last quarter. EverSource Wealth Advisors LLC lifted its stake in Envista by 378.0% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,414 shares of the company’s stock worth $47,000 after acquiring an additional 1,909 shares in the last quarter. Finally, Parallel Advisors LLC lifted its stake in Envista by 13.1% during the 4th quarter. Parallel Advisors LLC now owns 3,175 shares of the company’s stock worth $69,000 after acquiring an additional 367 shares in the last quarter.

Analysts Set New Price Targets

Several brokerages have recently commented on NVST. JPMorgan Chase & Co. upped their price target on Envista from $22.00 to $26.00 and gave the company a “neutral” rating in a research note on Friday, February 6th. Stifel Nicolaus set a $31.00 price target on Envista in a research note on Friday, February 6th. Wall Street Zen raised Envista from a “buy” rating to a “strong-buy” rating in a research note on Monday, January 26th. Barclays upped their price target on Envista from $24.00 to $34.00 and gave the company an “overweight” rating in a research note on Wednesday, February 11th. Finally, William Blair raised Envista from a “hold” rating to an “outperform” rating in a research note on Friday, February 6th. Six analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $28.25.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.